Search Results - "CİFTCİLER, Rafiye"

Refine Results
  1. 1

    Pathobiological Interactions of Local Bone Marrow Renin-Angiotensin System and Central Nervous System in Systemic Arterial Hypertension by Ciftciler, Rafiye, Haznedaroglu, Ibrahim Celalettin

    Published in Frontiers in endocrinology (Lausanne) (07-08-2020)
    “…Circulating renin-angiotensin system (RAS) and local paracrin-autocrin-intracrin tissue-based RAS participate in numerous pathobiological events…”
    Get full text
    Journal Article
  2. 2

    COVID-19, Renin-Angiotensin System, and Hematopoiesis by Çiftçiler, Rafiye, Haznedaroğlu, İbrahim C.

    Published in Turkish journal of haematology (01-01-2020)
    “…We had initially indicated that there is a local hematopoietic bone marrow (BM) renin-angiotensin system (RAS), active in the physiological and pathological…”
    Get full text
    Journal Article
  3. 3

    Prediction of Stem Cell Mobilization Failure in Patients with Hodgkin and Non-Hodgkin Lymphoma by Demiroğlu, Haluk, Çiftçiler, Rafiye, Büyükaşık, Yahya, Göker, Hakan

    Published in Turkish journal of haematology (01-01-2021)
    “…Autologous stem cell transplantation (ASCT) is a significant and potentially curative treatment modality for patients with relapsed/refractory lymphoma…”
    Get full text
    Journal Article
  4. 4

    Ankaferd hemostat: from molecules to medicine by ÇİFTÇİLER, Rafiye, HAZNEDAROĞLU, İbrahim Celalettin

    Published in Turkish journal of medical sciences (03-11-2020)
    “…Ankaferd hemostat (ABS; Ankaferd Blood Stopper®, İstanbul, Turkey) is a hemostatic agent having an impact on red blood cell–fibrinogen interactions. The…”
    Get full text
    Journal Article
  5. 5

    DEVELOPMENT OF GIANT PLASMACYTOMA IN A PATIENT WITH BONE MARROW RESPONSE DURING TREATMENT: A CASE REPORT by Rafiye Ciftciler, Serhat Sayın, Mehmet Daglı

    Published in Hematology, Transfusion and Cell Therapy (01-10-2023)
    “…Objective: A plasmacytoma is a myelomatous mass that can develop into a widespread illness, be seen alone, or be combined with multiple myeloma (MM). Bone…”
    Get full text
    Journal Article
  6. 6

    A Systematic Review on Second Treatment-Free Remission (TFR) Attempt in Chronic Myeloid Leukemia (CML): Can it be Applied in Clinical Practice? by Çiftçiler, Rafiye, Akın, Mehmet G., Erat, Zeynep, Eşkazan, A. Emre

    Published in Clinical lymphoma, myeloma and leukemia (01-01-2023)
    “…The prognosis and life expectancy of chronic myeloid leukemia (CML) patients have improved significantly with the launch of first tyrosine kinase inhibitor…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Impact of Hemoglobin, Leucocyte and Thrombocyte Levels at Diagnosis on the Survival Outcomes of Chronic Myeloid Leukemia Patients by DEMİRCİOĞLU, Sinan, CİFTCİLER, Rafiye, TEKİNALP, Atakan, KARS, Taha Ulutan

    Published in Genel tip dergisi (29-02-2024)
    “…Background:Since the development of tyrosine kinase inhibitors (TKIs), the prognosis for chronic myeloid leukemia (CML) has significantly improved. Several…”
    Get full text
    Journal Article
  9. 9

    Comprehensive Assessment of Common Medical Problems in Adult Patients with Hemophilia A: A Single-Center Experience in Turkey by Aydın,Mürüvvet Seda, Çiftçiler,Rafiye, İnkaya,Ahmet Çağkan, Aksu,Salih

    Published in Gazi tıp dergisi (01-01-2022)
    “…Objective: Chronic age related medical problems and blood-borne viral infections may be overlooked by the clinicians in Hemophilia A, and likewise Hemophilia A…”
    Get full text
    Journal Article
  10. 10

    Evaluation of the Survival Outcomes of Multiple Myeloma Patients According to their Plasmacytoma Presentation at Diagnosis by Çiftçiler, Rafiye, Göker, Hakan, Demiroğlu, Haluk, Aksu, Salih, Sayınalp, Nilgun, Haznedaroğlu, İbrahim C., Malkan, Ümit Yavuz, Büyükaşık, Yahya, Özcebe, Osman

    Published in Turkish journal of haematology (01-01-2020)
    “…Multiple myeloma (MM) associated with extramedullary (EM) plasmacytoma has a poor therapeutic response and poor outcomes when treated with conventional…”
    Get full text
    Journal Article
  11. 11

    On Being a “Physician Patient” with His Own Experimental Therapeutic Drug by Çiftçiler, Rafiye, Haznedaroğlu, İbrahim C.

    Published in Turkish journal of haematology (2018)
    “…We have read with great interest the paper by Patıroğlu et al. [1] on the mucosal healing effects of Ankaferd BloodStopper (ABS), recently published in this…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Effects of Smoking on Hematological Parameters and Ferritin Levels by Çiftçiler, Rafiye, Güven, Alper, Haznedaroğlu, İbrahim Celalettin, Aksu, Salih

    Published in Haseki tıp bülteni (01-12-2019)
    “…Aim: Cigarette smoking is associated with an increased risk of cardiovascular diseases, including coronary artery disease, peripheral vascular disease,…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    EVALUATION OF VITAMIN D STATUS IN ADULT PATIENTS WITH IMMUNE THROMBOCYTOPENIA by Rafiye Ciftciler, Cevdet Yıldırımel, Ali Erdinç Çiftçiler, Esra Seçkin, Mehmet Dağlı

    Published in Hematology, Transfusion and Cell Therapy (01-10-2023)
    “…Objective: 25-OH-vitamin D has been demonstrated to have immunomodulatory effects in addition to maintaining calcium and bone homeostasis. Numerous autoimmune…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper) by Ciftciler, Rafiye, Ciftciler, Ali Erdinc, Malkan, Umit Yavuz, Haznedaroglu, Ibrahim C

    Published in SAGE Open Medicine (2020)
    “…Ankaferd hemostat (Ankaferd blood stopper [ABS], Istanbul, Turkey) is a hemostatic agent affecting red blood cell-fibrinogen interactions. ABS has been…”
    Get full text
    Book Review Journal Article